These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 14644704

  • 1. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups.
    Weissbrich B, Langmann P, Schubert J, Jassoy C, Klinker H.
    Eur J Med Res; 2003 Nov 12; 8(11):495-8. PubMed ID: 14644704
    [Abstract] [Full Text] [Related]

  • 2. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.
    AIDS; 2006 May 12; 20(8):1171-9. PubMed ID: 16691069
    [Abstract] [Full Text] [Related]

  • 3. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
    Endo T, Fujimoto K, Nishio M, Yamamoto S, Obara M, Sato N, Koike T.
    J Med Virol; 2009 Jun 12; 81(6):979-82. PubMed ID: 19382259
    [Abstract] [Full Text] [Related]

  • 4. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
    Asmuth DM, Busch MP, Laycock ME, Mohr BA, Kalish LA, van der Horst CM, Viral Activation Transfusion Study (VATS) Group.
    Antiviral Res; 2004 Aug 15; 63(2):123-31. PubMed ID: 15302141
    [Abstract] [Full Text] [Related]

  • 6. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Bani-Sadr F, Goderel I, Morand P, Payan C, Lunel F, Pol S, Perronne C, Carrat F, Cacoub P.
    AIDS; 2007 Jul 31; 21(12):1645-8. PubMed ID: 17630563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.
    Shuhart MC, Sullivan DG, Bekele K, Harrington RD, Kitahata MM, Mathisen TL, Thomassen LV, Emerson SS, Gretch DR.
    J Infect Dis; 2006 May 01; 193(9):1211-8. PubMed ID: 16586356
    [Abstract] [Full Text] [Related]

  • 11. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
    Vallet-Pichard A, Pol S.
    J Hepatol; 2006 May 01; 44(1 Suppl):S28-34. PubMed ID: 16343684
    [Abstract] [Full Text] [Related]

  • 12. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
    Zeitoun JD, Mallet V, Chaix ML, Viard JP, Blanche S, Pol S.
    J Clin Virol; 2007 Sep 01; 40(1):71-3. PubMed ID: 17658294
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
    Cooper CL, Mills E, Angel JB.
    AIDS; 2007 Jan 02; 21(1):71-6. PubMed ID: 17148970
    [Abstract] [Full Text] [Related]

  • 16. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
    Petoumenos K, Ringland C, Australian HIV Observational Database.
    HIV Med; 2005 May 02; 6(3):155-63. PubMed ID: 15876281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C, Alberola J, Tamarit A, Navarro D.
    Clin Microbiol Infect; 2006 Jun 02; 12(6):555-60. PubMed ID: 16700705
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.